Epidemiological Integration of Genetic Variants and Metabolomics Profiles in Washington Heights Columbia Aging Project
Epidemiological Integration of Genetic Variants and Metabolomics Profiles in Washington Heights Columbia Aging Project
批准号:
10661335
负责人:
RICHARD P MAYEUX
金额:
$264.61万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-30 至 2024-08-31
关键词:
Administrative SupplementAgeAgingAlzheimer&aposs DiseaseAwardBiological MarkersBiologyChemicalsClinicalCollaborationsCommunitiesConsultationsDataDementiaDiseaseEnvironmental ExposureEpidemiologyEthnic OriginFAIR principlesFosteringFundingGoalsHomeInfrastructureInstitutesInstitutionInterest GroupLaboratoriesLeadLiquid substanceMass Spectrum AnalysisMeasuresMethodsMonitorParentsPathogenesisPilot ProjectsPopulationProcessProtocols documentationPublicationsQuality ControlRaceReference StandardsResearchResearch InfrastructureResearch PersonnelResearch SupportResolutionResourcesSamplingScienceSystemTestingTimeTrainingUniversitiesWashingtonauthoritybasedashboarddata sharingfollow-upgenetic variantimprovedinsightinstrumentationinterestmass spectrometermembermetabolomicsnovelnovel markeroperationpathology imagingprogramsprotocol developmentrecruitremote sensingtrait
中文摘要
摘要
AD环境驱动因素特征的暴露组学(EXCEL AD)的目标是提供
研究基础设施,将暴露组学纳入AD/ADRD研究。加里·米勒博士,创始董事
在埃默里大学大力神暴露体研究中心,建立了一个暴露组学实验室
在哥伦比亚大学的CTSA内,并与哥伦比亚阿尔茨海默病研究中心的几名成员合作
中锋(梅尤、泰奇、霍尼格、兰提瓜、斯特恩)。与这些人和其他AD/ADRD调查人员一起在
在哥伦比亚大学,他将促进将暴露组学纳入哥伦比亚大学额外的AD/ADRD研究。在……里面
此外,米勒博士将帮助发展和领导一个由NIA资助的国家AD/ADRD研究小组之间的网络
对暴露组学感兴趣,包括共享方案、方法、分析参考标准、
工作流程和结果,目的是协调AD研究中的暴露数据。我们假设
暴露组学将有助于识别AD的新生物标记物,提供对疾病发病机制的洞察,并确定
在不同种族和民族中观察到的与AD相关的差异的环境因素。Excel AD
我将通过以下目标来检验这一假设。目标1.提高容量、吞吐量和
外源和内源化学特性的鉴定
分辨率质谱学能力。随着我们结合LC/GC分析更多的AD样本
Orbitrap平台上,我们将发现与疾病特征(现有生物标记物、病理学、
影像、临床特征),需要对未知峰值进行后续识别和表征。这一努力
需要专门的仪器;因此,我们将获得最先进的高分辨率质谱仪
(Thermo IQ-X三联质谱仪),以帮助识别AD相关特征。目标2.目标
使用非靶向暴露组学和代谢组学为ADRC调查人员执行试点研究
站台。哥伦比亚大学正在进行多项AD/ADRD研究,覆盖了一系列人群
具有不同的种族、疾病阶段和年龄。我们将向哥伦比亚广告公司提供曝光组学方面的咨询
社区,并进行试点研究。此外,我们还将为选定的外部合作伙伴提供分析。穿过
在这一补充中,我们预计将资助六个项目(哥伦比亚大学三个,外部三个),这些项目有足够的能力产生
发布质量的结果。目标3.通过在线EXCEL AD开发、优化和分发工作流
社区仪表板和其他ADRC和AD研究小组有兴趣将
在他们的研究中暴露了经济学。我们将提供培训、质量控制协议和材料,以及访问
向哥伦比亚以外的AD/ADRD调查人员暴露标准。社区仪表板将编译
并整理正在进行的AD研究的信息,这些研究纳入了暴露组学和其他措施
促进AD的环境因素,包括地理空间分析、基于卫星的遥感和个人
监视器。这将为AD/ADRD暴露组学提供一个智力家园,并促进公平的数据做法。
英文摘要
ABSTRACT
The objective of Exposomics for Characterization of Environmental Drivers of AD (EXCEL AD) is to provide the
research infrastructure to incorporate exposomics into AD/ADRD research. Dr. Gary Miller, the founding director
of the HERCULES Exposome Research Center at Emory University, has established an Exposomics Laboratory
within Columbia’s CTSA and collaborated with several members of the Columbia Alzheimer’s Disease Research
Center (Mayeux, Teich, Honig, Lantigua, Stern). Together with these and other AD/ADRD investigators at
Columbia, he will facilitate the incorporation of exposomics into additional AD/ADRD studies at Columbia. In
addition, Dr. Miller will help develop and lead a network among national NIA-funded AD/ADRD research groups
interested in exposomics that will include sharing of protocols, methods, analytical reference standards,
workflows, and results with a goal of harmonizing exposome data across AD studies. We hypothesize that
exposomics will help identify novel biomarkers of AD, provide insight into disease pathogenesis, and identify
environmental contributors to the AD-related disparities observed in different races and ethnicities. EXCEL AD
will test this hypothesis through the following aims. Aim 1. To improve capacity, throughput, and
identification of exogenous and endogenous chemical features through expansion of our high-
resolution mass spectrometry capabilities. As we analyze more AD samples with our combined LC/GC
Orbitrap platform, we will uncover significant associations with disease traits (existing biomarkers, pathology,
imaging, clinical features) that require follow-up identification and characterization of unknown peaks. This effort
requires dedicated instrumentation; thus, we will acquire a state-of-the-art high-resolution mass spectrometer
(Thermo IQ-X Tribrid Mass Spectrometer) to aid in the identification of AD-associated features. Aim 2. To
perform pilot studies for ADRC investigators using the untargeted exposomics and metabolomics
platform. There are multiple AD/ADRD studies underway at Columbia University covering a range of populations
with diverse ethnicity, disease stage, and age. We will provide consultations on exposomics to the Columbia AD
community and perform pilot studies. In addition, we will provide analysis for select external partners. Through
this supplement, we anticipate funding six projects (3 at Columbia, 3 outside) of sufficient power to yield
publication-quality results. Aim 3. To develop, optimize, and distribute workflows via an online EXCEL AD
Community Dashboard among other ADRCs and AD research groups interested in incorporating
exposomics into their studies. We will provide training, quality control protocols and materials, and access to
exposome standards to AD/ADRD investigators outside of Columbia. The Community Dashboard will compile
and curate information on ongoing AD studies that are incorporating exposomics and other measures of
environmental contributors to AD, including geospatial analysis, satellite-based remote sensing, and personal
monitors. This will provide an intellectual home for AD/ADRD exposomics and promote FAIR data practices.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order
-
批准号:10171755
-
项目类别:
-
资助金额:$229.35万
-
财政年份:2020
-
负责人:RICHARD P MAYEUX
-
依托单位:
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order
-
批准号:10381723
-
项目类别:
-
资助金额:$228.26万
-
财政年份:2020
-
负责人:RICHARD P MAYEUX
-
依托单位:
Epidemiological Integration of Genetic Variants and Metabolomics Profiles in Washington Heights Columbia Aging Project
-
批准号:10055447
-
项目类别:
-
资助金额:$871.04万
-
财政年份:2020
-
负责人:RICHARD P MAYEUX
-
依托单位:
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order
-
批准号:9975379
-
项目类别:
-
资助金额:$229.97万
-
财政年份:2020
-
负责人:RICHARD P MAYEUX
-
依托单位:
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order
-
批准号:10611371
-
项目类别:
-
资助金额:$241.13万
-
财政年份:2020
-
负责人:RICHARD P MAYEUX
-
依托单位:
Additional Sequencing Cohorts for the Alzheimer's Disease Sequencing Project
-
批准号:10241931
-
项目类别:
-
资助金额:$175.85万
-
财政年份:2019
-
负责人:RICHARD P MAYEUX
-
依托单位:
Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS)
-
批准号:10242839
-
项目类别:
-
资助金额:$462.64万
-
财政年份:2017
-
负责人:RICHARD P MAYEUX
-
依托单位:
Whole Genome Sequencing in Ethnically Diverse Cohorts for the ADSP Follow-Up Study (FUS)
-
批准号:9757653
-
项目类别:
-
资助金额:$195.52万
-
财政年份:2017
-
负责人:RICHARD P MAYEUX
-
依托单位:
Epidemiology of Familial Late-Onset Alzheimer's Disease
-
批准号:8827233
-
项目类别:
-
资助金额:$82.43万
-
财政年份:2012
-
负责人:RICHARD P MAYEUX
-
依托单位:
Epidemiology of Familial Late-Onset Alzheimer's Disease
-
批准号:8459411
-
项目类别:
-
资助金额:$75.86万
-
财政年份:2012
-
负责人:RICHARD P MAYEUX
-
依托单位:
Epidemiology of Familial Late-Onset Alzheimer's Disease
-
批准号:8269305
-
项目类别:
-
资助金额:$93.56万
-
财政年份:2012
-
负责人:RICHARD P MAYEUX
-
依托单位:
Epidemiology of Familial Late-Onset Alzheimer's Disease
-
批准号:8658369
-
项目类别:
-
资助金额:$84.94万
-
财政年份:2012
-
负责人:RICHARD P MAYEUX
-
依托单位:
Allele-specific Mapping in Alzheimer's Disease
-
批准号:8286216
-
项目类别:
-
资助金额:$12.8万
-
财政年份:2010
-
负责人:RICHARD P MAYEUX
-
依托单位:
Epidemiology of Biomarkers of Risk and Progression in LOAD
-
批准号:8667384
-
项目类别:
-
资助金额:$194.67万
-
财政年份:2010
-
负责人:RICHARD P MAYEUX
-
依托单位:
Epidemiology of Biomarkers of Risk and Progression in LOAD
-
批准号:7908090
-
项目类别:
-
资助金额:$197.84万
-
财政年份:2010
-
负责人:RICHARD P MAYEUX
-
依托单位:
Allele-specific Mapping in Alzheimer's Disease
-
批准号:8661660
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2010
-
负责人:RICHARD P MAYEUX
-
依托单位:
Epidemiology of Biomarkers of Risk and Progression in LOAD
-
批准号:8453403
-
项目类别:
-
资助金额:$184.91万
-
财政年份:2010
-
负责人:RICHARD P MAYEUX
-
依托单位:
Allele-specific Mapping in Alzheimer's Disease
-
批准号:8065505
-
项目类别:
-
资助金额:$13.09万
-
财政年份:2010
-
负责人:RICHARD P MAYEUX
-
依托单位:
Epidemiology of Biomarkers of Risk and Progression in LOAD
-
批准号:8067916
-
项目类别:
-
资助金额:$198.25万
-
财政年份:2010
-
负责人:RICHARD P MAYEUX
-
依托单位:
Allele-specific Mapping in Alzheimer's Disease
-
批准号:8462882
-
项目类别:
-
资助金额:$9.37万
-
财政年份:2010
-
负责人:RICHARD P MAYEUX
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: